latest from tivo-3: tivozanib for refractory advanced renal cell carcinoma
Published 5 years ago • 270 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:44
tivo-3: tivozanib hydrochloride vs sorafenib for refractory advanced rcc
-
1:41
tivozanib tolerability shows potential advantage for patients with advanced rcc
-
4:18
tivozanib for refractory advanced rcc
-
12:49
the tivo-3 study of tivozanib in metastatic renal cell carcinoma
-
2:16
further evaluation of tivozanib shows promise for relapsed, refractory renal cell carcinoma
-
1:00
dr. vaishampayan on the potential of tivozanib in advanced rcc
-
0:59
data support use of tivozanib in patients with advanced renal cell carcinoma
-
22:35
recent advance in tivozanib plus nivolumab combinatorial strategies in advanced renal cell carcinoma
-
24:39
sernova eyes range of disease for implantable cell technology
-
4:43
cappuccino with claudio ronco: 366. discovery and application of new selective cytopheretic device
-
4:09
3. dialysis - decoded & demystified: introduction to the dialyzer - the core of dialysis
-
1:28
dr. motzer on the tivo-3 trial examining tivozanib in advanced rcc
-
2:43
adverse effect profile for tivozanib plus sorafenib for relapsed/refractory renal cell carcinoma
-
0:52
dr. pal on the rationale for the tivo-3 trial with tivozanib in advanced rcc
-
4:07
tivo-3 results point to tivozanib activity after rcc progression on axitinib | brian rini
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
0:33
rana mckay, md, offers impressions of the tivo-3 study in highly refractory advanced rcc patients
-
1:24
dr. motzer on the tivo-1 trial with tivozanib in advanced rcc
-
2:06
dr. rini discusses tivozanib in advanced rcc
-
0:50
dr. pal on the benefit of tivozanib in later-line settings for refractory rcc
-
1:15
tivozanib could evaluated in combination regimens for renal cell carcinoma
-
17:02
dr. pedro barata: overview of fotivda® (tivozanib)